GHD | Investments | Nordic Capital
GHD.jpg

GHD

Medical Homecare Products and Services

GHD is the market leading homecare provider in Germany, delivering medical products, advice and services to more than 140,000 patients. The company operates in the German healthcare market, which is characterised by positive long-term demand driven by demographic trends.

Company Background

  • Longstanding expertise with +30 years in the German healthcare market.
  • Integrated business model that combines the production of medical supplies and compounded pharmaceuticals with wholesale and logistics activities.
  • A leading producer of custom-made infusion solutions for cytostatic drugs and parenteral nutrition.

Vision & Outlook

  • Support continued accelerated growth, both organically and through acquisitions.
  • Drive further growth in homecare and adjacent healthcare segments, as well as by developing new business areas.

Highlights & Updates

  • Launch of new digital guidance service for home-based patients in Germany during the corona pandemic with helpful videos and hygiene tips.
ghd-corporate logo.png

SECTOR

Healthcare

REVENUES 2022

EUR 590 million

EMPLOYEES

2,205

OWNERSHIP

Fund VIII

INVESTMENT DATE

2014

HEAD OFFICE

Ahrensburg, Germany

MANAGEMENT

Dr. Chima Abuba

CEO

Matthias Born

CFO